SCHEMBL19953258

SCHEMBL19953258

COC(=O)c1cc2c(cn1)ncn2Cc1cccc(C(=O)Nc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.46
GRK2 P25098 1/20 0.46
FLT3 P36888 1/20 0.44
SLC2A1 P11166 1/20 0.43
FAAH O00519 1/20 0.43
MGLL Q99685 1/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 2/20 0.42
CNR1 P21554 1/20 0.42
HPGD P15428 1/20 0.42
KDR P35968 1/20 0.42
HIF1A Q16665 1/20 0.41
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1869252 0.86 ALDH1A1 (0.49) FLT3SMN1; SMN2ALDH1A1MMP13
SCHEMBL19964496 0.84 IDO1 (0.48) IDO1GRK2FLT3SLC2A1FAAH
SCHEMBL19964494 0.83 FLT3 (0.46) IDO1GRK2FLT3SLC2A1FAAH
SCHEMBL19964310 0.83 LOXL2 (0.53) IDO1GRK2FLT3SLC2A1FAAH
SCHEMBL19964536 0.78 FLT3 (0.42) IDO1GRK2FLT3SLC2A1FAAH
SCHEMBL2945788 0.75 MMP13 (0.48) IDO1FLT3SMN1; SMN2ALDH1A1MMP13
SCHEMBL13085846 0.75 IDO1 (0.64) IDO1ALDH1A1
SCHEMBL1867752 0.73 CYP11B1 (0.55) FLT3SMN1; SMN2ALDH1A1MMP13
SCHEMBL30202437 0.72 BRD4 (0.59) IDO1FLT3SMN1; SMN2ALDH1A1CNR1
SCHEMBL17807884 0.72 BRD4 (0.59) IDO1FLT3SMN1; SMN2ALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048930-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2018-03-15 WO disclosed
WO-2018048930-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2018-03-15 WO disclosed